A new study presented at CROI 2019 explored whether switching to monthly long-acting CAB+RPV is noninferior to continuing current 3-drug oral ART in adults with virologically suppressed HIV-1 infection.
...
Alveolar macrophages play an important role in host defense against pathogenic microorganisms and tissue remodeling. In their study, Dr Charles P. Neff and colleagues investigated the effect of HIV and...
At CROI 2019, Dr Rosie Mngqibisa presented results from her study that evaluated whether concurrent use of rifampicin and efavirenz impacts the efficacy of DMPA, a commonly used contraceptive.
The relationship between COPD and myocardial infarction among individuals with HIV is not as well understood as in those without HIV. Researchers sought to define the relationship in individuals with HIV;...
New research presented at CROI 2019 compared the efficacy and safety of ART containing an integrase inhibitor with efavirenz (EFV) when initiated during pregnancy.
At CROI 2019, Dr Cindy Firnhaber presented results from her study that evaluated the efficacy of the HPV vaccine as adjuvant therapy among women with HIV and high-grade squamous intraepithelial lesion.
...
During her presentation at CROI 2019, Dr Constance A. Benson reviewed the steps that have been taken to improve the outlook of tuberculosis and what still needs to be done.
A program offering long-acting no-cost contraception to U.S. girls and women aged 15 to 19 reduced the teenage pregnancy rate by 79% over 5 years and cut the abortion rate by 77%.
